Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -81,058 | -125,467 | -11,178 | -58,983 | -45,992 |
| Depreciation Amortization | 85 | 56 | 28 | 44 | 33 |
| Accounts payable and accrued liabilities | -1,137 | -2,827 | -3,094 | 3,083 | 1,324 |
| Other Working Capital | -7,239 | -5,460 | -4,199 | 4,753 | 6,742 |
| Other Operating Activity | 37,537 | 101,398 | 5,411 | 8,129 | 7,661 |
| Operating Cash Flow | $-51,812 | $-32,300 | $-13,032 | $-42,973 | $-30,232 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 30,000 | 30,000 |
| Debt Repayment | -4 | -4 | -3 | -10,232 | -10,229 |
| Common Stock Issued | 60,449 | 56,141 | N/A | 30,024 | 27,597 |
| Other Financing Activity | 0 | 0 | 0 | -824 | -824 |
| Financing Cash Flow | $60,444 | $56,137 | $-3 | $48,969 | $46,544 |
| Beginning Cash Position | 23,392 | 23,392 | 23,392 | 17,397 | 17,397 |
| End Cash Position | 32,024 | 47,229 | 10,357 | 23,392 | 33,709 |
| Net Cash Flow | $8,632 | $23,837 | $-13,035 | $5,995 | $16,312 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,812 | -32,300 | -13,032 | -42,973 | -30,232 |
| Free Cash Flow | -51,812 | -32,300 | -13,032 | -42,973 | -30,232 |